Insights into the conformational switching mechanism of the human vascular endothelial growth factor receptor type 2

Matteo Chioccioli1, Simone Marsili, Claudia Bonaccini

  • 1Laboratory of Molecular Modeling Cheminformatics and QSAR, Department of Pharmaceutical Sciences, University of Firenze, Via Ugo Schiff 6, I-50019 Sesto Fiorentino, Firenze Italy.

Insights

Human vascular endothelial growth factor receptor type 2 (h-VEFGR2) kinase domain undergoes conformational changes crucial for drug targeting. Molecular dynamics simulations reveal intermediate states, aiding the design of selective anticancer drugs.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Human vascular endothelial growth factor receptor type 2 (h-VEFGR2) is a key regulator of angiogenesis and a significant target for anticancer drug development.
  • The receptor's kinase domain undergoes conformational changes, particularly involving the αC-helix and A-loop, which are critical for its activation and inactivation.
  • Understanding these conformational dynamics is essential for designing selective kinase inhibitors.

Purpose of the Study:

  • To investigate the conformational landscape of the kinase domain receptor (KDR) domain using molecular dynamics simulations.
  • To identify intermediate conformations between the active (DFG-in) and inactive (DFG-out) states.
  • To elucidate the atomistic mechanisms regulating A-loop opening and KDR domain conformational switching.

Main Methods:

  • Utilized molecular dynamics simulations to explore the conformational space of the KDR domain.
  • Employed targeted energy modifications to facilitate and observe the A-loop opening mechanism.
  • Analyzed simulation trajectories to identify rare intermediate conformations.

Main Results:

  • Successfully observed the KDR domain transitioning from the DFG-out conformation.
  • Identified novel intermediate conformations between the DFG-out and DFG-in states.
  • Provided atomistic insights into the regulation of the A-loop opening mechanism.

Conclusions:

  • Detailed knowledge of KDR domain conformational dynamics is vital for structure-based drug discovery.
  • The identified intermediate conformations represent potential new targets for enhancing inhibitor selectivity and efficacy.
  • This study provides a foundation for rational drug design targeting h-VEFGR2.

Related Concept Videos

Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...